The use of antibiotic resistance genes as selection markers in synthetic biology strains has been a common practice for many years. However, the increasing concern over the spread of antibiotic resistance has prompted scientists to develop alternative selection systems. The use of antibiotic-free selection systems is not only a safer option but also more cost-effective in the long run.
Genetic circuits are complex systems of interacting genes that can be designed to perform specific functions, such as producing valuable chemicals or sensing environmental signals. The field of synthetic biology has enabled the creation of increasingly sophisticated genetic circuits, which has great potential for various industries. CD Biosynsis provides a wide range of services for genetic circuits design in this field.
DNA assembly and cloning are critical techniques in synthetic biology that enable researchers to create and modify DNA sequences for various applications, including gene editing, protein engineering, and synthetic biology. Traditional cloning methods, such as restriction enzyme digestion and ligation, can be time-consuming and often result in unwanted mutations or errors. However, recent advancements in DNA assembly and cloning techniques have enabled researchers to construct complex DNA sequences with greater speed, accuracy, and efficiency.
In recent years, the field of synthetic biology has made significant advancements in developing new genetic systems that allow for precise and efficient control of gene expression and editing. One promising approach is the use of orthogonal genetic systems, which enable the simultaneous regulation and editing of multiple genes with high specificity and efficiency. CD Biosynsis is leading the way in providing cutting-edge services in this exciting orthogonal genetic systems field.
In the field of synthetic biology, genetically modified organisms (GMOs) have been engineered to produce a variety of products at an industrial scale. However, concerns have been raised surrounding the ecological risks associated with the release of GMOs outside of controlled environments. Biocontainment systems are needed to neutralize these GMOs and prevent them from causing harm to the environment. In addition, alternative selection markers are needed to replace costly and risky antibiotics.
Cell-free systems are gaining popularity as a platform for protein synthesis due to their rapid and efficient nature. These systems are free from cell walls and membranes and can be used to synthesize proteins directly from DNA templates. They offer several advantages over traditional methods of protein expression, including increased speed, simplicity, and cost-effectiveness. Synthetic biology has played a significant role in advancing cell-free systems by providing new methods for DNA synthesis and assembly, as well as new enzymes and substrates for protein synthesis.
Whole-cell biosynthesis is a rapidly growing field in synthetic biology that involves the use of living cells as a platform for the production of valuable compounds. This approach offers a number of advantages over traditional chemical synthesis, including improved efficiency, reduced waste, and the ability to use renewable resources. CD Biosynsis is a leading company in the field of whole-cell biosynthesis, providing a range of services for the production of a wide variety of compounds using genetically modified microorganisms.
Spore engineering is a cutting-edge technology that has revolutionized the field of synthetic biology. It involves the genetic modification of bacterial spores, which are highly resistant structures that can survive harsh environmental conditions. Spore engineering has various applications in the fields of bioremediation, bioproduction, drug delivery, and biosensing. CD Biosynsis is a leading company in spore engineering, providing innovative solutions to meet the needs of our clients.
Synthetic biology has emerged as a promising approach for engineering microorganisms to perform complex metabolic tasks, including biodegradation. Biodegradation pathway engineering involves the modification of microbial metabolism to degrade specific contaminants or pollutants. At CD Biosynsis, we offer a range of services for biodegradation pathway engineering, utilizing the latest synthetic biology tools and techniques to design and optimize microbial consortia for biodegradation applications.
Custom cell line development services offer specialized solutions for creating and optimizing cell lines tailored to specific research, therapeutic, or biotechnological needs. Our services provide comprehensive support from initial consultation to final validation, ensuring that your custom cell lines meet your precise requirements for functionality, stability, and reproducibility.
De novo protein design is revolutionizing synthetic biology by enabling the creation of tailor-made proteins with unprecedented functions. Our services empower industries and researchers to harness the potential of these engineered biomolecules for diverse applications, from therapeutics to materials science.
Our high-throughput screening services are dedicated to assisting researchers and organizations in achieving their scientific goals efficiently and effectively, leveraging state-of-the-art technology and expertise to accelerate progress in diverse fields of study.
CD Biosynsis provides high-quality data analysis services for the learn phase of synthetic biology to help researchers around the world facilitate their cutting-edge research. We have the ability and extensive experience to help bring diverse synthetic biology applications and creative ideas to fruition.
CD Biosynsis is committed to providing high-quality services to our clients. Our specialized synthetic biology platform specializes in providing tools, libraries of gene parts for metabolic pathways, and bioengineering for chemical production, as well as designing and optimizing metabolic pathways for maximum efficiency.
Automation screening is a pivotal technology in synthetic biology, revolutionizing research across various domains. By harnessing the power of automation, CD Biosynsis' services contribute to the advancement of life sciences, enabling rapid, systematic, and high-throughput analysis that was previously unattainable through manual methods.
CD Biosynsis provides experimental redesign services for the "learn" phase of synthetic biology to help researchers around the world facilitate their cutting-edge research. We have the ability and extensive experience to help bring diverse synthetic biology applications and creative ideas to fruition.
CD Biosynsis has expertise in pathway engineering, computational tools, and collaborative approaches that are well suited to meet the diverse needs of our clients in synthetic biotechnology.
Genetic Engineering is the manipulation of an organism's genetic material to introduce desired characteristics or traits. It involves altering the DNA sequence of an organism to achieve specific outcomes, such as increased crop yield or improved disease resistance.
In silico screening is revolutionizing synthetic biology by offering a powerful and cost-effective approach to biological research and drug discovery. Our comprehensive services, coupled with cutting-edge technology and expert guidance, position us at the forefront of this transformative field. Unlock the full potential of your research with our In Silico Screening Services.
Site-directed mutagenesis is a very useful in vitro technique to create specific, targeted mutations in a known DNA sequence. It can efficiently change the characterization of target proteins. Site-directed mutagenesis can be used as a precision tool to enable synthetic biology. It plays an essential role in a variety of synthetic biology research, such as the study of gene regulatory elements, protein structure and functions, enzyme active sites and novel proteins.
CD Biosynsis provides a comprehensive suite of tools to accelerate your synthetic biology research. By harnessing the power of high-throughput screening and in-depth characterization, we empower researchers and innovators to unlock the full potential of biological systems for a wide range of applications, from drug discovery to biotechnology advancements.
CD Biosynsis has a team of experienced and highly skilled scientists to provide synthetic biology researchers around the world with high-quality cell-based protein expression services to facilitate their cutting-edge research.
Metabolic engineering and synthetic biology have combined to become one of the most promising fields. CD Biosynsis provides a comprehensive portfolio of metabolic services for the build phase of the Design-Build-Test-Learn (DBTL) cycle to help synthetic biology researchers around the world facilitate their cutting-edge research. We provide powerful tools and tailored solutions to help our customers overcome the challenges in synthetic biology and bring diverse creative ideas to fruition.
CD Biosynsis provides comprehensive services for plant metabolic engineering to facilitate the cutting-edge research of synthetic biology researchers around the world.
CD Biosynsis provides professional backbone building services for synthetic biology researchers around the world to facilitate their cutting-edge research. Our aim is to obtain protein backbone configurations that satisfy a set of predefined requirements by the customers.
CD Biosynsis has advanced design automation platforms and extensive experience to help synthetic biology researchers around the world facilitate their cutting-edge research.
Plant strain modification, also known as plant breeding or genetic engineering, involves the deliberate alteration of a plant's genetic makeup to achieve specific desired traits. This process aims to improve crop yield, quality, resistance to pests and diseases, and tolerance to various environmental conditions. Plant strain modification is a powerful tool in plant biotechnology that enables the manipulation of plant traits to improve crop yields, enhance disease resistance, and increase nutritional value.
CD Biosynsis provides professional enzyme engineering services to facilitate the cutting-edge research of synthetic biology researchers around the world.
CD Biosynsis provides comprehensive cellular analysis for the test phase of synthetic biology to help researchers around the world facilitate their cutting-edge research. Equipment with an advanced technology platform and powerful synthetic biology tools, we have the ability to help bring diverse synthetic biology applications and creative ideas to fruition.
CD Biosynsis provides one-stop experimental design services to help synthetic biology researchers around the world to facilitate their cutting-edge research.
Strain characterization and analysis are crucial steps in understanding the properties and behavior of microorganisms. Accurate characterization of strains is essential in various fields such as agriculture, biotechnology, medicine, and environmental science. At CD Biosynsis, we offer a range of services for strain characterization and analysis, including phenotypic characterization, genotypic analysis, and bioinformatics analysis.
CD Biosynsis provides comprehensive bacterial cellular engineering services to facilitate the cutting-edge research of synthetic biology researchers around the world.
CD Biosynsis provides a wide range of metabolite analysis services for the test phase of synthetic biology to help researchers around the world facilitate their cutting-edge research. Equipment with an advanced technology platform and powerful synthetic biology tools, we have the ability to help bring diverse synthetic biology applications and creative ideas to fruition.
In recent years, the integration of digital experimentation (DE) and design of experiments (DOE) services has revolutionized the design phase of the DBTL cycle, enhancing efficiency and accelerating innovation. CD Biosynsis is dedicated to providing professional digital experimentation and DOE services to help researchers around the world advance their cutting-edge research.
CD Biosynsis provides high-quality database building services for the "learn" phase of synthetic biology to help researchers around the world facilitate their cutting-edge research. We have the ability and extensive experience to help bring diverse synthetic biology applications and creative ideas to fruition.
Synthetic biology is a rapidly growing field that has revolutionized the way we think about the production of biological compounds. One of the key challenges in synthetic biology is the optimization of metabolic pathways in strains to produce high-value compounds. Metabolic pathway optimization involves the design, engineering, and optimization of the enzymatic and regulatory processes that control the production of specific compounds in microbial cells. However, the complexity of cellular metabolism and the limited understanding of the underlying mechanisms make the optimization of metabolic pathways a tedious and time-consuming process. Therefore, new approaches are required to accelerate the pathway optimization process and improve the efficiency and accuracy of the metabolic engineering process.
Through DNA assembly and cloning services, CD Biosynsis aims to provide researchers and innovators with streamlined access to complex genetic constructs, which will alleviate the technological challenges associated with DNA manipulation and enable researchers to focus on their core objectives, facilitating their breakthroughs in different fields.
Plasmids are small, self-replicating circular DNA molecules that play a crucial role in synthetic biology. They are used to introduce genes of interest into host cells, allowing for the manipulation and engineering of biological systems.
Genetic engineering has revolutionized various industries, including healthcare, agriculture, and biomanufacturing. The field of synthetic biology, which involves the design and construction of new biological systems or redesigning existing ones, has further expanded the possibilities of genetic engineering. Genetic engineering has been a rapidly evolving field over the past few decades, with the development of new technologies and techniques that have made it possible to manipulate genes with unprecedented precision and efficiency. The potential of genetic engineering to revolutionize various industries has been well-established, but it also raises ethical and regulatory challenges that need to be addressed.
In the rapidly advancing field of synthetic biology, the performance evaluation of strains plays a pivotal role in optimizing biological systems for various applications. Synthetic biology combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems with enhanced functionalities.
Fermentation is a fundamental biological process that has been used for centuries to produce a wide range of products, including food, beverages, pharmaceuticals, and biofuels. Traditional methods of fermentation monitoring involve time-consuming and costly methods such as manual sampling and offline analysis. However, monitoring the fermentation process in real-time can be challenging due to the complex interactions between microorganisms, substrates, and environmental factors.
CD Biosynsis provides custom genome reprogramming services for synthetic biology researchers around the world to facilitate their cutting-edge research. Our strong expertise coupled with advanced techniques can help bring diverse synthetic applications and creative ideas to fruition.
CD Biosynsis provides professional in silico and experimental validation services for synthetic biology researchers around the world to facilitate their cutting-edge research.
Metabolic engineering is a rapidly growing field that involves the design and construction of microbial cells for the production of high-value compounds. The optimization of metabolic pathways is a crucial step in this process, as it can significantly improve the efficiency and accuracy of production.
Synthetic biology involves engineering biological systems through the design and construction of new biological parts, devices, and systems, or the modification of existing ones. One of the key challenges in synthetic biology is to create efficient and reliable metabolic pathways in microbial strains.
In a world where scientific breakthroughs hinge on innovative tools, our novel CRISPR system stands at the forefront of genetic engineering innovation. With its precision, versatility, and diverse applications, it empowers researchers and industry leaders to push the boundaries of what's possible in the realm of synthetic biology.
CD Biosynsis's synthetic biology platform is dedicated to providing high-quality protein library design services to help biologists around the world design protein variant collections to support innovation in a variety of fields.
Strain improvement is a critical aspect of synthetic biology that involves the targeted enhancement of microorganisms or cell lines for specific applications. It revolves around modifying the genetic, metabolic, and physiological characteristics of these organisms to optimize their performance in various industrial, medical, or research contexts.
Metabolic network modeling is a powerful tool for understanding the complex interactions between biological systems and their environments. It involves the use of computational techniques to analyze and simulate the metabolic pathways in organisms, with the goal of predicting their behavior under different conditions. In recent years, metabolic network modeling has become increasingly important in synthetic biology, where it is used to design and optimize strains for a wide range of applications.
DNA vector construction is a fundamental technique in molecular biology that involves creating recombinant DNA molecules for various applications. It plays a crucial role in genetic engineering, gene therapy, and biotechnology research. By designing and assembling DNA sequences into a vector, which acts as a carrier, DNA vector construction enables the delivery of desired genetic material into target cells or organisms. This process is essential for manipulating and studying genes, as well as for developing new treatments and therapies.
Synthetic biology is a rapidly growing field that has the potential to revolutionize many industries, including biotechnology, medicine, and agriculture. One of the key tools in synthetic biology is gene editing, which allows scientists to manipulate the DNA of organisms to create new functions, optimize metabolic pathways, and engineer new traits. In recent years, the development of new gene editing tools, such as CRISPR-Cas9, has made gene editing faster, cheaper, and more precise than ever before.
CD Biosynsis provides comprehensive pathway design services for synthetic biology researchers around the world to facilitate their cutting-edge research.
Codon optimization is a crucial technique used to strategically modify the genetic code of a gene in order to enhance protein expression in a specific host organism. By fine-tuning codon usage, we can significantly improve protein production yield, enhance protein functionality, and increase overall efficiency.
Plasmid DNA Preparation is a crucial process in molecular biology that involves isolating and purifying plasmid DNA from bacterial cells. Plasmids are small, circular DNA molecules commonly used in genetic engineering and research. Plasmid DNA Preparation ensures the production of high-quality and pure DNA samples for various applications such as cloning, gene expression studies, and genetic engineering experiments.
PCR Cloning is a powerful molecular biology technique that allows scientists to amplify a specific DNA sequence and insert it into a vector for further study or manipulation. This method has revolutionized the field of genetic engineering by enabling the creation of multiple copies of DNA fragments, which can be used for various applications in molecular biology and biotechnology.
SgRNA (short guide RNA) design is the process of designing RNA molecules for the CRISPR-Cas9 genome editing tool. The CRISPR-Cas9 system is composed of Cas9 protein and guiding RNA (sgRNA), which can accurately cleave specific DNA sequences, thereby achieving genome editing and repair.
CRISPR-Cas9 sgRNA synthesis refers to the use of molecular biology techniques to synthesize sgRNA (single guide RNA) molecules in the CRISPR-Cas9 system. CRISPR-Cas9 is a technology used for gene editing that can accurately modify DNA sequences. SgRNA is a key component of the CRISPR-Cas9 system, which can guide Cas9 enzymes to locate target DNA sequences and perform cleavage or repair. Therefore, synthesizing sgRNA is a necessary step for conducting CRISPR-Cas9 gene editing experiments. The synthesis of sgRNA is usually achieved through in vitro synthesis methods, using chemical synthesis or in vitro transcription.
CD Biosynsis specializes in Biosynthesis of gene cluster services, offering cutting-edge solutions for synthetic biology applications. Our comprehensive services encompass gene cluster analysis, design, and optimization to drive innovation in biotechnology.
CD Biosynsis harnesses the transformative power of the Cell-Free System to catalyze innovation across the biotech landscape. With an unwavering focus on precision, quality, and versatility, we empower researchers and biotech entities to explore new horizons and unlock the full potential of molecular biology. Join us on the journey to redefine the future of biotechnology through our pioneering Cell-Free System Services.
CD Biosynsis specializes in cutting-edge protein biosynthesis services. Leveraging synthetic biology techniques, we deliver precise and efficient protein synthesis solutions tailored to your unique research and industrial needs.
Our Salmonella Genome Editing Service offers precise and efficient solutions for genetic modifications in Salmonella species, optimizing them for use in research, vaccine development. Utilizing state-of-the-art genome editing technologies such as CRISPR/Cas9, we provide comprehensive support from project design to final validation, ensuring your genome editing goals are achieved with high accuracy and efficiency.
Our Pseudomonas aeruginosa Genome Editing Service offers precise and efficient solutions for genetic modifications in Pseudomonas aeruginosa, optimizing them for use in research, industrial applications, and medical biotechnology. Utilizing state-of-the-art genome editing technologies such as CRISPR/Cas9, TALENs, and recombineering, we provide comprehensive support from project design to final validation, ensuring your genome editing goals are achieved with high accuracy and efficiency.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.